Hepatocellular Carcinoma MCQ — NEET PG Practice Question | NEETPGAI
Hepatocellular Carcinoma
hard
microscope Pathology
A 62-year-old woman with HCV-related cirrhosis (Child-Pugh A5) undergoes screening ultrasound which shows a 2.2 cm hypoechoic nodule in segment 7. Contrast-enhanced CT shows arterial phase enhancement but no definite washout in the portal venous phase. AFP is 45 ng/mL. What is the most appropriate next step?
A. Perform MRI with hepatobiliary contrast to confirm diagnosis
B. Perform ultrasound-guided biopsy of the nodule
C. Diagnose HCC and proceed to TACE
D. Repeat contrast-enhanced CT in 3 months
Explanation
Diagnostic Uncertainty in Intermediate-Risk Nodules
Key Point
A nodule 1–2 cm with arterial enhancement but WITHOUT definite washout on one imaging modality does NOT meet diagnostic criteria for HCC. A second imaging modality is required.
AASLD Diagnostic Algorithm for Nodules 1–2 cm
Loading diagram...
High-YieldNEET PG
For nodules 1–2 cm, arterial enhancement + washout on TWO imaging modalities is required for diagnosis. If only one modality shows both features, a second imaging study is mandatory.
Why MRI is the Best Second Modality Here
1.
Complementary imaging: MRI with hepatobiliary contrast (gadoxetate) has superior sensitivity for detecting washout in small nodules
2.
Tissue characterization: Hepatobiliary contrast agents provide additional information (hepatobiliary phase) unavailable on CT
3.
No additional radiation: Unlike repeat CT, MRI avoids radiation exposure
4.
High diagnostic accuracy: MRI detects washout in >80% of HCCs when CT is equivocal
Clinical Pearl
Gadoxetate-enhanced MRI is the gold standard for resolving diagnostic uncertainty in nodules 1–2 cm with equivocal CT findings.
Warning
Do NOT diagnose HCC on arterial enhancement alone in a nodule <2 cm without washout confirmation. This leads to overdiagnosis and unnecessary treatment.
Loading illustration…
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.